"Alerted.org

The Associate Director (AD), Biostatistics, leads the full scope of statistical contribution to a clinical development program. The AD provides statistical strategies for the clinical trials and regulatory submissions and is accountable for the statistical deliverables within the program. ( Positions available supporting multiple Therapeutic Areas available )

Main Responsibilities:

+ Lead full scope of Biostatistics conduct for the responsible program within a therapeutic area. Define statistical strategy and ensure appropriate statistical methodologies applied to study design and data analysis for clinical trials and regulatory submissions

+ Influence and contribute to clinical development plans, collaborate with cross-functional team for governance reviews.

+ Lead statistical strategy for planning and study execution (member of Study Executive Team, Clinical Development Team) and quantitative evaluation to clinical trials, regulatory submissions, and related documents.

+ Provide statistical thought partnership for innovative study design and clinical development plans, including Go-No Go criteria and probability of technical success calculations.

+ Provide for project-wide planning of analyses; quality and timely delivery of interim and final results, including integrated analyses for submissions.

+ Represent Biostatistics in interactions with regulatory authorities (eg, FDA, EMA, PMDA)

+ Be responsible for interpreting analysis results and ensuring reporting accuracy in study reports and regulatory documents.

+ Manage outsourcing operations or work with internal statistical programmers within the responsible program. Ensure timeliness and quality of deliverables by CRO/FSP.

+ Support or lead improvement initiatives within the department, organization and/or pharma industry.

+ Prepare abstracts, posters, oral presentations and written reports to effectively communicate results of clinical programs and studies to internal and external stakeholders and colleagues with varying levels of clinical research knowledge.

Education and Experience:

+ PhD with 8 years of experience or MS with 11 years of experience in drug development

+ Experience providing statistical leadership at compound/indication level

+ Demonstrated statistical expertise and leadership in facilitating and optimizing the (pre/early/full-) clinical development strategy

+ Solid experience in applications of advanced statistical methodologies

+ Leading roles in regulatory submissions

+ Experience in interactions with major regulatory authorities preferred

+ Experience with CROs (either managing a CRO, or having worked in a CRO) or managing internal deliveries preferred

+ Track record of innovation preferred

Competencies:

+ Familiarity with regulatory guidance and interactions -Broad knowledge of clinical development and processes

+ Ability to collaboratively work and provide leadership in matrix environment -Strong interpersonal and communication skills (verbal and written in English)

+ Good working knowledge of SAS and/or R

+ Expertise in a range of statistical methodologies

+ Demonstrated use of innovative / creative methodology for analysis of clinical data

+ Familiarity with relevant regulatory guidance documents

Expertise in:

+ CDISC, statistical programming, and/or data standards

+ Biostatistics and Statistical Programming Operations

About CSL Behring

CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients’ needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead full lives.

CSL Behring operates one of the world’s largest plasma collection networks, CSL Plasma. Our parent company, CSL, headquartered in Melbourne, Australia, employs 32,000 people, and delivers its lifesaving therapies to people in more than 100 countries.

To learn more about CSL, CSL Behring, CSL Seqirus and CSL Vifor visit https://www.csl.com/ and CSL Plasma at https://www.cslplasma.com/ .

Our Benefits

For more information on CSL benefits visit How CSL Supports Your Well-being | CSL (https://www.csl.com/careers/your-well-being) .

You Belong at CSL

At CSL, Inclusion and Belonging is at the core of our mission and who we are. It fuels our innovation day in and day out. By celebrating our differences and creating a culture of curiosity and empathy, we are able to better understand and connect with our patients and donors, foster strong relationships with our stakeholders, and sustain a diverse workforce that will move our company and industry into the future.

To learn more about inclusion and belonging visit https://www.csl.com/careers/inclusion-and-belonging

Equal Opportunity Employer

CSL is an Equal Opportunity Employer. If you are an individual with a disability and need a reasonable accommodation for any part of the application process, please visit https://www.csl.com/accessibility-statement .

R-263047

CSL makes all employment decisions without regard to race, color, religion, national origin, ancestry, age, sex, gender, pregnancy, disability, marital status, sexual orientation, gender identity, genetic information, military status, protected veteran status (specifically status as a disabled veteran, recently separated veteran, armed forces service medal veteran, or active duty wartime or campaign badge veteran) or other classification protected by applicable US federal, state or local law. CSL complies with all applicable employment laws, including but not limited to Title VII of the Civil Rights Act of 1964, the Americans with Disabilities Act, the Fair Labor Standards Act, and the Immigration Reform and Control Act. https://www.cslbehring.com/careers/eeo-statement